» Articles » PMID: 36306822

Children with Malignancies and Septic Shock - an Attempt to Understand the Risk Factors

Overview
Specialty Pediatrics
Date 2022 Oct 28
PMID 36306822
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To explain the high mortality of septic shock in children with cancer.

Methods: A retrospective cohort from 2016 to 2020, of children aged 0 to 18 years, and septic shock.

Results: The authors included 139 patients. Acute lymphocytic leukemia was the most frequent diagnosis (16.5%), and Gram-negative bacteria were the most frequent blood culture isolates (22.3%). There were 57 deaths in ICU (41%), 10 in the first 24 hours of shock (early death). A LASSO model with variables: neutropenia (coefficient 0.215), respiratory (0.81), hematological (1.41), and neurological (0.72) dysfunctions, age (-0.002) and solid tumor recurrence (0.34) generated AUC = 0.79 for the early death outcome. Survivors had significant differences in the PRISM-IV score (mean ± SD 10.9 ± 6.2 in the survivors, 14.1 ± 6.5 in the deceased, p = 0.004), and in the mean number of organ dysfunctions (3.2 ± 1.1 in the survivors, 3.8 ± 6.5 in the deceased, p < 0.001). A positive fluid balance in the first 24 hours of sepsis between 2% and 6% of body weight showed a reduction effect on the probability of death in ICU (hazard ratio 0.47, 95% CI 0.24-0.92, p = 0.027). The recurrence of any cancer was a predictor of in-hospital death, regardless of severity.

Conclusions: Recurrence of any cancer is an important risk of sepsis-related death. A positive fluid balance between 20 and 60 mL/kg or 2% and 6% of body weight in the first 24 hours after the onset of sepsis is related to lower mortality.

Citing Articles

Comparing the clinical characteristics and outcomes of septic shock children with and without malignancies: a retrospective cohort study.

Huang H, Zhang R, Chen J, Dang H, Liu C, Lu S J Pediatr (Rio J). 2024; 100(6):633-639.

PMID: 38968957 PMC: 11662747. DOI: 10.1016/j.jped.2024.06.003.


Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series.

Chen S, Chang T, Wang Y, Lee E, Lin J, Hsiao Y Cancers (Basel). 2024; 16(8).

PMID: 38672594 PMC: 11048420. DOI: 10.3390/cancers16081512.


Management of septic shock in children with cancer-Common challenges and research priorities.

Agulnik A J Pediatr (Rio J). 2023; 99(2):101-104.

PMID: 36706794 PMC: 10031354. DOI: 10.1016/j.jped.2023.01.001.

References
1.
Calton E, Le Doare K, Appleby G, Chisholm J, Sharland M, Ladhani S . Invasive bacterial and fungal infections in paediatric patients with cancer: incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009-2011. Pediatr Blood Cancer. 2014; 61(7):1239-45. DOI: 10.1002/pbc.24995. View

2.
Yoo J, Jung Y, Ahn J, Choi Y, Lee K, Hur S . Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers. J Gynecol Oncol. 2020; 31(5):e62. PMC: 7440980. DOI: 10.3802/jgo.2020.31.e62. View

3.
Simon A, Bode U, Beutel K . Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect. 2006; 12(7):606-20. DOI: 10.1111/j.1469-0691.2006.01416.x. View

4.
McIntosh A, Tong S, Deakyne S, Davidson J, Scott H . Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis. Pediatr Crit Care Med. 2017; 18(8):750-757. PMC: 5548505. DOI: 10.1097/PCC.0000000000001191. View

5.
Ceneviva G, Paschall J, Maffei F, Carcillo J . Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics. 1998; 102(2):e19. DOI: 10.1542/peds.102.2.e19. View